Release Date: 31/01/13 12:31 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 154.23KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%